Thoracic oncology
Symposium
Malignant pleural effusions
Clinical
Aims : To present the recently completed statement of the ERS task force on malignant pleural effusions and the primary results of AMPLE 2 and TAPPS, which are two recent randomised controlled trials on pleural malignancy. An update on the results of recent trials on the oncological management of mesothelioma will also be provided.
Target audience :
Clinical researcher, Thoracic oncologist, Thoracic surgeon, Adult pulmonologist/Clinician
Methods :
General respiratory patient care
14:45
2018 ERS-EACTS statement on malignant pleural effusions
A. Bibby(Bristol (Avon), United Kingdom)
COI
-
Description
1
4936
15:15
What is the best oncological management strategy for mesothelioma in 2018?
A. Scherpereel(Lille Cedex, France)
COI
-
Description
2
4937
15:45
Talc slurry vs. talc poudrage: primary results of the TAPPS trial
R. Bhatnagar(Bristol, United Kingdom)
COI
-
Description
3
4938
16:15
Regular vs. symptomatic drainage of indwelling pleural catheters: primary results of the AMPLE 2 trial
G. Lee(Perth (WA), Australia)
COI
-
Description
4
4939
. . .
